The European Society
of Human Genetics

Calls for collaboration

Calls for collaboration

canSERV - Invitation to join the European Network for Personalized Oncology and its European Molecular Tumor Board Network

A european-wide initiative by the EU cluster project canSERV

We would like to invite anyone involved in a Molecular Tumor Board (MTB) – e.g., physicians, scientists, patient representatives, ethicists – to join the European Network for Personalised Oncology (ENPO) and its European Molecular Tumor Board Network (EMTBN), both being established through the EU cluster project canSERV (visit canSERV About). The European Network for Personalised Oncology (ENPO) aims to provide state-of-the-art guidance and support to accelerate the implementation of personalised oncology. Through canSERV, the ENPO will establish the European Molecular Tumor Board Network (EMTBN), which aims to guide the establishment of MTB Standard Operating Procedures (consensus standards) and the set-up of a public registry of MTB recommendation outcomes. The ENPO and EMTBN will not be limited to the canSERV consortium partners but open to the wider community to be as inclusive and engaging as possible. Although participation in the networks is on a voluntary basis, some specific activities can be considered for cost reimbursement for those who will actively contribute.

More information

canSERV - Call for Service Provision on ”Advancing Personalised Oncology"

The canSERV Consortium announces its first Challenge-Call on

“Advancing Personalised Oncology”.

Cancer Researchers in, and outside the EU are invited to apply for free access to cutting-edge transnational services with an indicative overall budget of EUR 500,000. The aim of this call is to accelerate knowledge gain in personalised oncology with specific emphasis on multi-level data-based treatment guidance linked to Molecular Tumour Boards1.

The projects supported under this call will support the advancement and implementation of personalized medicine strategies for all cancer patients in Europe, contributing to the overarching goals of the Cancer Mission Board.

More information

IGPrare Project - Partnership between Aix-Marseille University and EURODIS

This research project, elaborated in collaboration with Eurordis (, aims to study the genetic information disclosure to a patient's family in case of a diagnosis of rare genetic disease, and to propose solutions to improve the efficiency and acceptability of this procedure in the future.

This European scale study aims to identify and review the different legal framework and ethical recommendations elaborated in European countries to disclose genetic information to family members.

You can find further information here.

If you are a geneticist or genetic counsellor please and you would like to take part, Please complete the questionnaire ( It should take about 10 minutes. Your input would be very much appreciated.

Please contact Marion Gottrau if you have any questions.